CBPO - China Biologic Products Holdings, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
4.42B
Enterprise Value 3
3.64B
Trailing P/E
30.60
Forward P/E 1
24.27
PEG Ratio (5 yr expected) 1
2.83
Price/Sales (ttm)
8.85
Price/Book (mrq)
2.60
Enterprise Value/Revenue 3
7.30
Enterprise Value/EBITDA 6
19.45

Trading Information

Stock Price History

Beta (3Y Monthly) 0.84
52-Week Change 364.06%
S&P500 52-Week Change 38.78%
52 Week High 3116.63
52 Week Low 360.08
50-Day Moving Average 3110.18
200-Day Moving Average 398.74

Share Statistics

Avg Vol (3 month) 3158.93k
Avg Vol (10 day) 395.47k
Shares Outstanding 538.26M
Float 16.39M
% Held by Insiders 144.13%
% Held by Institutions 147.35%
Shares Short (Sep 30, 2019) 4520.72k
Short Ratio (Sep 30, 2019) 42.39
Short % of Float (Sep 30, 2019) 41.86%
Short % of Shares Outstanding (Sep 30, 2019) 41.36%
Shares Short (prior month Aug 30, 2019) 41M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 29.46%
Operating Margin (ttm)32.71%

Management Effectiveness

Return on Assets (ttm)6.02%
Return on Equity (ttm)11.09%

Income Statement

Revenue (ttm)499.52M
Revenue Per Share (ttm)13.09
Quarterly Revenue Growth (yoy)12.70%
Gross Profit (ttm)320.09M
EBITDA 187.41M
Net Income Avi to Common (ttm)144.1M
Diluted EPS (ttm)3.78
Quarterly Earnings Growth (yoy)45.40%

Balance Sheet

Total Cash (mrq)917.47M
Total Cash Per Share (mrq)23.98
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)10.57
Book Value Per Share (mrq)44.48

Cash Flow Statement

Operating Cash Flow (ttm)152.63M
Levered Free Cash Flow (ttm)60.76M